Skip to main content


March 02, 2019
Objective: To evaluate the efficacy of dasotraline in the treatment of secondary behavioral and psychological outcomes in patients with Binge-eating disorder (BED).
December 07, 2017
This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Background Binge eating disorder (BED) is the most common eating disorder with a US prevalence of 2.8%. This study evaluated dasotraline, a novel dopamine and norepinephrine reuptake…
November 29, 2017
The economic burden of binge-eating disorder (BED) in the US is not well quantified. This claims analysis compared healthcare utilization and costs of commercially insured enrollees with and without BED from the MarketScanВ Commercial Database.
January 27, 2016
This study reports changes in global wellbeing, as well as improvements in each of these five elements. Each of the eight trackable components (mood, anxiety, exercise, mindfulness, sleep, social connectedness, emotional eating, mental wellness) showed numeric improvements and all met statistical…
Back to Top